NeuPath Health treats myofascial pain, neuropathic pain, diabetic neuropathic pain, and chronic headaches.
NeuPath Health has raised $9.4M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in March 2025.
NeuPath Health's investors include Royal Bank of Canada, National Bank of Canada.
NeuPath Health is headquartered in Mississauga, Canada.
NeuPath Health treats myofascial pain, neuropathic pain, diabetic neuropathic pain, and chronic headaches.
NeuPath Health is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeuPath Health — Funding & Investors." VCBacked, March 27, 2025, https://www.vcbacked.co/company/neupath-health. Accessed August 14, 2026.
VCBacked. (2025). NeuPath Health — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/neupath-health
{{cite web |title=NeuPath Health — Funding & Investors |url=https://www.vcbacked.co/company/neupath-health |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated